EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beyond the kidney biopsy: genomic approach to undetermined kidney diseases

Thomas Robert iD, Laure Raymond, Marine Dancer, Julia Torrents, Noémie Jourde-Chiche, Stéphane Burtey, Christophe Béroud, Laurent Mesnard

Clinical Kidney Journal · 04.01.2024 · 17 (1)

DOI: 10.1093/ckj/sfad099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 25.04.2023. Verfasst von Thomas Robert und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

According to data from large national registries, almost 20%–25% of patients with end-stage kidney disease have an undetermined kidney disease (UKD). Recent data have shown that monogenic disease-causing variants are under-diagnosed. We performed exome sequencing (ES) on UKD patients in our center to improve the diagnosis rate.

Methods

ES was proposed in routine practice for patients with UKD including kidney biopsy from January 2019 to December 2021. Mutations were detected using a targeted bioinformatic customized kidney gene panel (675 genes). The pathogenicity was assessed using American College of Medical Genetics guidelines.

Results

We included 230 adult patients, median age 47.5 years. Consanguinity was reported by 25 patients. A family history of kidney disease was documented in 115 patients (50%). Kidney biopsies were either inconclusive in 69 patients (30.1%) or impossible in 71 (30.9%). We detected 28 monogenic renal disorders in 75 (32.6%) patients. Collagenopathies was the most common genetic kidney diagnosis (46.7%), with COL4A3 and COL4A4 accounting for 80% of these diagnoses. Tubulopathies (16%) and ciliopathies (14.7%) yielded, respectively, the second and third genetic kidney diagnosis category and UMOD-associated nephropathy as the main genetic findings for tubulopathies (7/11). Ten of the 22 patients having ES “first” eventually received a positive diagnosis, thereby avoiding 11 biopsies. Among the 44 patients with glomerular, tubulo-interstitial or vascular nephropathy, 13 (29.5%) were phenocopies. The diagnostic yield of ES was higher in female patients (P = .02) and in patients with a family history of kidney disease (P < .0001), reaching 56.8% when the patient had both first- and second-degree family history of renal disease.

Conclusion

Genetic diagnosis has provided new clinical insights by clarifying or reclassifying kidney disease etiology in over a third of UKD patients. Exome “first” may have a significant positive diagnostic yield, thus avoiding invasive kidney biopsy; moreover, the diagnostic yield remains elevated even when biopsy is impossible or inconclusive. ES provides a clinical benefit for routine nephrological healthcare in patients with UKD.

Schlagwörter

Stichwörter der Autor:innen

chronic kidney diseaseexome sequencingundetermined nephropathy

Autor:innen und Institutionen

  • Centre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
  • Marseille Medical Genetics, Bioinformatics & Genetics, INSERM U1251, Aix-Marseille Université, Marseille, France.
  • Genetics Department, Laboratoire Eurofins Biomnis, Lyon, France.
  • Department of Renal Pathology, CHU Timone, AP-HM, Marseille, France.
  • Aix-Marseille Univ, INSERM, INRAE, C2VN, Marseille, France.
  • Urgences Néphrologiques et Transplantation Rénale, Sorbonne Université, APHP, Hôpital Tenon, Paris, France.

ORCID-Profile: Thomas Robert

Zitieren

APA

Robert, T., Raymond, L., Dancer, M., Torrents, J., Jourde-Chiche, N., Burtey, S., Béroud, C., & Mesnard, L. (2024). Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. Clinical Kidney Journal, 17(1). https://doi.org/10.1093/ckj/sfad099

Vancouver

Robert T, Raymond L, Dancer M, Torrents J, Jourde-Chiche N, Burtey S, et al. Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. Clinical Kidney Journal. 2024;17(1). doi:10.1093/ckj/sfad099

BibTeX
@article{Robert2024,
  author = {Robert, Thomas and Raymond, Laure and Dancer, Marine and Torrents, Julia and Jourde-Chiche, Noémie and Burtey, Stéphane and Béroud, Christophe and Mesnard, Laurent},
  title = {Beyond the kidney biopsy: genomic approach to undetermined kidney diseases},
  journal = {Clinical Kidney Journal},
  year = {2024},
  volume = {17},
  number = {1},
  doi = {10.1093/ckj/sfad099}
}
Kostenlos starten →